International Diabetes Federation gives grant to UMDNJ-University Hospital in Newark

Linda Siminerio, PhD, chair of the BRIDGES Review Committee said that the Federation is committed to converting research findings into useful practices for the provision of quality care and services delivered by healthcare providers. The BRIDGES translational research projects are selected because of their innovative ideas, demonstration of the potential for health care cost savings, sustainability plans and the opportunity for their results to be widely replicated in other settings.

“The University Hospital in Newark is a great example of science moves from a clinical setting into the communities that need it,” said Siminerio. “People living with diabetes in Newark will benefit from care that reflects and meets the needs of the challenges in their lives.”

For interviews

International Diabetes Federation, Kerrita McClaughlyn, Media Relations Manager, Email: Tel: +32-2-543-1639/ Mobile: +32-487-530625. Dale R. Heffler, Vice President of Communications, The Foundation of UMDNJ, , Tel: +1 732 235-3310 (New Jersey)

Note to editors:

The International Diabetes Federation (IDF) is the global advocate for the over 250 million people with diabetes worldwide. It represents over 200 diabetes associations in more than 160 countries. Its mission is to promote diabetes care, prevention and a cure worldwide. The International Diabetes Federation is an NGO in official relations with the World Health Organization and an associated NGO with the United Nations Department of Public Information. The International Diabetes Federation leads the World Diabetes Day campaign. Additional information is available at www.idf.org.

BRIDGES is the global translational grant programme of the International Diabetes Federation. It solicits proposals that support cost effective and sustainable interventions that can be adopted in real world settings, for the prevention and control of diabetes. Projects should be based on interventions already proven to be effective in trials to prevent and treat diabetes, to improve care of type 1 and type 2 diabetes and delay its complications. The interventions proposed should have the potential to be widely disseminated to clinical practice, individuals and communities. For more information, visit http://www.idfbridges.org.

University Hospital (UH) is a 513-bed acute care hospital owned and operated by UMDNJ located in the city of Newark. As the primary teaching hospital of the New Jersey Medical School (NJMS) in Newark, the hospital is committed to providing the highest quality of patient care, medical training and education, clinical research and community service. UH has a medical staff of 927, and is the largest medical teaching program in the state. Additional information is available at www.umdnj.edu